roclub, a Berlin, Germany–based teleoperation platform for medical technology, has secured $11.7 million in Series A funding.
Investors
The round was led by Smedvig Ventures and YZR, with participation from existing investor Speedinvest and several angel investors.
Smedvig Ventures is a prominent European venture capital firm that focuses on early-stage and growth-stage technology investments. It operates as the venture capital arm of the larger Smedvig Family Office. The firm invests in companies at the Series A and Series B stages in B2B (Business-to-Business) technology across Europe.
YZR Capital is a venture capital firm based in Munich, Germany, that specializes exclusively in backing early-stage technology companies in the healthcare sector. Founded in 2021, the firm invests in Pre-Seed, Seed, and Series A rounds.
roclub Use of Funds
The company will use the funding to support its U.S. expansion, further develop its teleoperation marketplace connecting healthcare providers with remote technologists, and continue innovating in AI-enabled medtech operations.
About roclub
Founded in 2022 by Dr. Matthias Issing and André Glardon, roclub is a B2B SaaS company that provides a teleoperation platform designed to transform the way medtech equipment is operated. Its platform enables healthcare providers to remotely operate medical equipment, starting with MRI and CT scanners. Powered by AI and cloud technology, roclub’s vendor-agnostic platform connects technologists with medical devices anywhere, improving utilization, reducing patient wait times, and ensuring continuous access to care. Headquartered in Berlin, Germany, roclub currently operates in 11 countries, serving some of the world’s largest diagnostic imaging providers in hospitals and outpatient facilities.
Funding Details
Company: roclub GmbH
Raised: $11.7M
Round: Series A
Funding Date: October 2025
Lead Investors: Smedvig Ventures, YZR
Additional Investors: Speedinvest, angel investors
Company Website: https://www.roclub.com/
Software Category: Healthtech / Medtech Teleoperation / AI SaaS
Source: Scott Rosenblum, LEVEL PR